share_log

Bright Horizons Family Analyst Ratings

Benzinga ·  Jul 17, 2023 06:02
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating
07/17/2023 3.39% BMO Capital → $99 Downgrades Outperform → Market Perform
06/26/2023 -36.29% Morgan Stanley $57 → $61 Maintains Underweight
06/01/2023 -17.49% UBS → $79 Initiates Coverage On → Sell
05/26/2023 1.31% Goldman Sachs $87 → $97 Maintains Buy
05/12/2023 5.48% Citigroup $95 → $101 Downgrades Buy → Neutral
03/03/2023 -0.78% Citigroup $92 → $95 Maintains Buy
02/21/2023 -14.36% Goldman Sachs $94 → $82 Maintains Buy
02/21/2023 -15.4% BMO Capital $84 → $81 Maintains Outperform
02/17/2023 -14.36% Goldman Sachs $94 → $82 Maintains Buy
02/17/2023 -20.63% Baird $68 → $76 Maintains Neutral
12/02/2022 -21.67% Barclays → $75 Downgrades Overweight → Equal-Weight
11/03/2022 -3.92% Citigroup $115 → $92 Maintains Buy
11/02/2022 -1.83% Goldman Sachs $108 → $94 Maintains Buy
11/02/2022 -40.47% Morgan Stanley $60 → $57 Maintains Underweight
10/19/2022 12.79% Goldman Sachs $125 → $108 Maintains Buy
10/10/2022 -21.67% Barclays $90 → $75 Maintains Overweight
09/27/2022 -37.34% Morgan Stanley $72 → $60 Maintains Underweight
08/18/2022 -24.8% Morgan Stanley $77 → $72 Maintains Underweight
08/04/2022 9.66% BMO Capital $112 → $105 Maintains Outperform
08/04/2022 -6.01% Barclays $130 → $90 Maintains Overweight
08/03/2022 -19.58% Morgan Stanley $83 → $77 Maintains Underweight
08/03/2022 30.55% Goldman Sachs $144 → $125 Maintains Buy
07/20/2022 -13.32% Morgan Stanley $91 → $83 Maintains Underweight
05/04/2022 -4.96% Morgan Stanley $109 → $91 Maintains Underweight
05/04/2022 35.77% Barclays $155 → $130 Maintains Overweight
03/29/2022 19.06% Deutsche Bank → $114 Initiates Coverage On → Hold
01/05/2022 13.84% Morgan Stanley $111 → $109 Maintains Underweight
12/16/2021 15.93% Morgan Stanley $130 → $111 Maintains Underweight
12/13/2021 61.88% Barclays $180 → $155 Maintains Overweight
11/03/2021 35.77% Morgan Stanley $135 → $130 Maintains Underweight
09/23/2021 40.99% Morgan Stanley $139 → $135 Maintains Underweight
08/05/2021 45.17% Morgan Stanley $136 → $139 Maintains Underweight
07/06/2021 80.68% BMO Capital $158 → $173 Upgrades Market Perform → Outperform
05/19/2021 42.04% Morgan Stanley $150 → $136 Maintains Underweight
05/10/2021 77.55% Citigroup → $170 Upgrades Neutral → Buy
04/07/2021 56.66% Morgan Stanley → $150 Downgrades Equal-Weight → Underweight
02/19/2021 98.43% Barclays $145 → $190 Maintains Overweight
02/18/2021 75.46% BMO Capital $150 → $168 Maintains Market Perform
01/06/2021 59.79% Morgan Stanley $136 → $153 Maintains Equal-Weight
11/09/2020 42.04% Morgan Stanley $125 → $136 Maintains Equal-Weight
11/02/2020 56.66% Baird → $150 Downgrades Outperform → Neutral
10/20/2020 30.55% Morgan Stanley $115 → $125 Maintains Equal-Weight
10/06/2020 56.66% BMO Capital $127 → $150 Downgrades Outperform → Market Perform
08/06/2020 32.64% BMO Capital $125 → $127 Maintains Outperform
08/06/2020 20.1% Morgan Stanley $107 → $115 Maintains Equal-Weight
07/10/2020 11.75% Morgan Stanley $106 → $107 Maintains Equal-Weight
05/08/2020 27.42% Citigroup $80 → $122 Maintains Neutral
05/07/2020 30.55% BMO Capital $128 → $125 Maintains Outperform
05/07/2020 -0.78% B of A Securities $97 → $95 Reiterates → Underperform
05/07/2020 10.7% Morgan Stanley $100 → $106 Maintains Equal-Weight
04/22/2020 4.44% Morgan Stanley $95 → $100 Maintains Equal-Weight
04/21/2020 33.68% BMO Capital $100 → $128 Maintains Outperform
04/21/2020 40.99% Baird $95 → $135 Maintains Outperform
04/21/2020 B of A Securities Downgrades Neutral → Underperform
03/19/2020 -0.78% Baird → $95 Upgrades Neutral → Outperform
11/22/2019 84.86% Jefferies → $177 Initiates Coverage On → Buy
11/07/2019 58.75% Citigroup $154 → $152 Maintains Neutral
10/08/2019 69.19% Morgan Stanley → $162 Initiates Coverage On → Equal-Weight
09/11/2019 73.37% BMO Capital $152 → $166 Upgrades Market Perform → Outperform
06/20/2019 70.23% Goldman Sachs $135 → $163 Upgrades Neutral → Buy
03/04/2019 31.59% Citigroup $117 → $126 Maintains Neutral
03/01/2019 31.59% Citigroup $117 → $126 Maintains Neutral
02/13/2019 27.42% BMO Capital $120 → $122 Maintains Market Perform
11/06/2018 25.33% BMO Capital $123 → $120 Maintains Market Perform
11/02/2018 27.42% Baird $115 → $122 Maintains Neutral
11/02/2018 30.55% JP Morgan $121 → $125 Maintains Overweight
11/02/2018 30.55% Barclays $105 → $125 Maintains Overweight
08/06/2018 23.24% BMO Capital $114 → $118 Maintains Market Perform

What is the target price for Bright Horizons Family (BFAM)?

The latest price target for Bright Horizons Family (NYSE: BFAM) was reported by BMO Capital on July 17, 2023. The analyst firm set a price target for $99.00 expecting BFAM to rise to within 12 months (a possible 3.39% upside). 23 analyst firms have reported ratings in the last year.

What is the most recent analyst rating for Bright Horizons Family (BFAM)?

The latest analyst rating for Bright Horizons Family (NYSE: BFAM) was provided by BMO Capital, and Bright Horizons Family downgraded their market perform rating.

When is the next analyst rating going to be posted or updated for Bright Horizons Family (BFAM)?

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Bright Horizons Family, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Bright Horizons Family was filed on July 17, 2023 so you should expect the next rating to be made available sometime around July 17, 2024.

Is the Analyst Rating Bright Horizons Family (BFAM) correct?

While ratings are subjective and will change, the latest Bright Horizons Family (BFAM) rating was a downgraded with a price target of $0.00 to $99.00. The current price Bright Horizons Family (BFAM) is trading at is $95.75, which is within the analyst's predicted range.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment